165 related articles for article (PubMed ID: 11369927)
1. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
Hamouda B; Jamila Z; Najet R; Slim T; Rafiaa N; Noureddine B; Ahmed EM; Mohamed F; Ridha KM; Abderrahman L
J Am Acad Dermatol; 2001 Jun; 44(6):1054. PubMed ID: 11369927
[No Abstract] [Full Text] [Related]
2. [Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum].
Boussen H; Zwik J; Mili-Boussen I; Rammeh N; Bouaouina N; Gritli S; el May A; Kammoun MR; Ouertani A; Ladgham A
Therapie; 2001; 56(6):751-4. PubMed ID: 11878102
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cancer in a child with ocular xeroderma pigmentosa (XP) in Malawi.
Schulze Schwering M; Chagaluka G; Molyneux E
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e540-2. PubMed ID: 24390455
[TBL] [Abstract][Full Text] [Related]
4. Role of isotretinoin in cancer prevention and management in malignancies associated with xeroderma pigmentosum.
Zaman S; Gillani JA; Nabeela ; Khattak R; Iqbal ; ul Ain N; Zanaib ; Fayyaz
J Ayub Med Coll Abbottabad; 2014; 26(2):255-7. PubMed ID: 25603690
[TBL] [Abstract][Full Text] [Related]
5. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in patient with xeroderma pigmentosum.
Wolf P; Kerl H
Lancet; 1991 Jun; 337(8757):1613-4. PubMed ID: 1675745
[No Abstract] [Full Text] [Related]
7. [Spinocellular carcinoma of the upper lip in a child with Xeroderma pigmentosum].
Perrotta R; Tarico MS; Pompili G; Camilleri V
Pediatr Med Chir; 2009; 31(3):126-9. PubMed ID: 19739492
[TBL] [Abstract][Full Text] [Related]
8. [Multiple facial squamous cell carcinomas in a child, revealing a xeroderma pigmentosum].
Beogo R; Andonaba JB; Bouletreau P; Traore Sawadogo H; Traore A
Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):50-2. PubMed ID: 22056175
[TBL] [Abstract][Full Text] [Related]
9. Clinical remission of xeroderma pigmentosum-associated squamous cell carcinoma with isotretinoin and chemotherapy: case report.
Saade M; Debahy NE; Houjeily S
J Chemother; 1999 Aug; 11(4):313-7. PubMed ID: 10465136
[TBL] [Abstract][Full Text] [Related]
10. Treatment of superficial ulcerative squamous cell carcinoma in three horses with topical 5-fluorouracil.
Paterson S
Vet Rec; 1997 Dec; 141(24):626-8. PubMed ID: 9447676
[TBL] [Abstract][Full Text] [Related]
11. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.
Ameri AH; Mooradian MJ; Emerick KS; Park JC; Wirth LJ; Asgari MM; Tsao H; Lawrence D; Sullivan RJ; Demehri S
Br J Dermatol; 2019 Nov; 181(5):1095-1097. PubMed ID: 31102460
[No Abstract] [Full Text] [Related]
13. Bleomycin in xeroderma pigmentosum.
Short J; Price RA; Pratt CB
Cancer; 1973 Feb; 31(2):449-54. PubMed ID: 4120025
[No Abstract] [Full Text] [Related]
14. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
15. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.
Roseeuw D
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():30-2. PubMed ID: 14616810
[TBL] [Abstract][Full Text] [Related]
16. Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas.
Maxfield L; Shah M; Schwartz C; Tanner LS; Appel J
J Am Acad Dermatol; 2021 Jun; 84(6):1696-1697. PubMed ID: 33378661
[No Abstract] [Full Text] [Related]
17. High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xeroderma pigmentosum patients.
Matsumura Y; Sato M; Nishigori C; Zghal M; Yagi T; Imamura S; Takebe H
J Invest Dermatol; 1995 Sep; 105(3):399-401. PubMed ID: 7665920
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum with multiple malignancies.
Nalgirkar AR; Borkar SS; Nalgirkar SA
Indian Pediatr; 2000 Dec; 37(12):1377-9. PubMed ID: 11119344
[No Abstract] [Full Text] [Related]
19. Xeroderma pigmentosum: a Turkish case series.
Gül U; Kiliç A; Gönül M; Cakmak SK; Soylu S
Int J Dermatol; 2007 Nov; 46(11):1125-8. PubMed ID: 17988329
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy for cutaneous cancers with xeroderma pigmentosum].
Ben Salah H; Bahri M; Turki H; Abdelmoula M; Frikha M; Daoud J
Cancer Radiother; 2011 Aug; 15(5):400-3. PubMed ID: 21664850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
